4.2 Letter

Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic

Journal

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY
Volume 17, Issue 1, Pages 2053-2053

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.sapharm.2020.03.020

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available